Ligand Pharmaceuticals Inc <LGND.O>: Citigroup resumes coverage with buy rating; price target $387
LGND•Related News
Amex Halt CPHI.A Add Info Lst 1.590000
CPHI•
Trump administration to unveil forced labor trade action soon, says Greer
SPY•
American Resources affiliate ReElement adds 13 staff as rare earth refining demand grows
AREC•
SkinHealth Systems to report Q2 2026 results after market close, host investor call
SKIN•
Nasdaq Trade Halt <FEMY.O> Volatility Trading Pause at 10:10 AM
FEMY•